US Stock MarketDetailed Quotes

MLYS Mineralys Therapeutics

Watchlist
  • 12.950
  • -0.190-1.45%
Close Dec 11 16:00 ET
  • 12.950
  • 0.0000.00%
Post 16:02 ET
644.50MMarket Cap-4.20P/E (TTM)

Mineralys Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
128.77%60.11M
187.05%45.17M
136.73%35.36M
168.93%84.66M
176.89%27.71M
253.94%26.27M
142.86%15.74M
97.36%14.94M
68.11%31.48M
41.30%10.01M
Selling and administrative expenses
62.19%6.12M
53.08%5.9M
74.22%4.61M
173.40%14.3M
83.84%4.03M
176.69%3.77M
335.63%3.85M
234.39%2.65M
116.34%5.23M
368.95%2.19M
-General and administrative expense
62.19%6.12M
53.08%5.9M
74.22%4.61M
173.40%14.3M
83.84%4.03M
176.69%3.77M
335.63%3.85M
234.39%2.65M
116.34%5.23M
368.95%2.19M
Research and development costs
139.94%53.99M
230.47%39.27M
150.17%30.75M
168.04%70.36M
202.95%23.69M
271.33%22.5M
112.40%11.88M
81.37%12.29M
60.96%26.25M
18.17%7.82M
Operating profit
-128.77%-60.11M
-187.05%-45.17M
-136.73%-35.36M
-168.93%-84.66M
-176.89%-27.71M
-253.94%-26.27M
-142.86%-15.74M
-97.36%-14.94M
-68.11%-31.48M
-41.30%-10.01M
Net non-operating interest income expense
7.43%3.77M
15.56%4.15M
65.44%3.85M
661.10%12.76M
255.19%3.32M
374.09%3.51M
3.59M
2.33M
6,307.41%1.68M
935K
Non-operating interest income
7.43%3.77M
15.56%4.15M
65.44%3.85M
661.10%12.76M
255.19%3.32M
374.09%3.51M
--3.59M
--2.33M
--1.68M
--935K
Other net income (expense)
-10K
100.00%2K
0.00%1K
-25.00%3K
1K
1K
1K
100.61%4K
0
Other non- operating income (expenses)
---10K
100.00%2K
0.00%1K
-25.00%3K
--1K
----
--1K
--1K
300.00%4K
--0
Income before tax
-147.55%-56.34M
-237.81%-41.01M
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
Income tax
Net income
-147.55%-56.34M
-237.81%-41.01M
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
Net income continuous Operations
-147.55%-56.34M
-237.81%-41.01M
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
Minority interest income
Net income attributable to the parent company
-147.55%-56.34M
-237.81%-41.01M
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-147.55%-56.34M
-237.81%-41.01M
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
Basic earnings per share
-98.25%-1.13
-167.74%-0.83
-37.25%-0.7
-160.82%-1.99
-171.20%-0.63
55.81%-0.57
75.21%-0.31
65.09%-0.51
79.74%-0.763
83.01%-0.2323
Diluted earnings per share
-98.25%-1.13
-167.74%-0.83
-37.25%-0.7
-160.82%-1.99
-171.20%-0.63
55.81%-0.57
75.21%-0.31
65.09%-0.51
79.74%-0.763
83.01%-0.2323
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 128.77%60.11M187.05%45.17M136.73%35.36M168.93%84.66M176.89%27.71M253.94%26.27M142.86%15.74M97.36%14.94M68.11%31.48M41.30%10.01M
Selling and administrative expenses 62.19%6.12M53.08%5.9M74.22%4.61M173.40%14.3M83.84%4.03M176.69%3.77M335.63%3.85M234.39%2.65M116.34%5.23M368.95%2.19M
-General and administrative expense 62.19%6.12M53.08%5.9M74.22%4.61M173.40%14.3M83.84%4.03M176.69%3.77M335.63%3.85M234.39%2.65M116.34%5.23M368.95%2.19M
Research and development costs 139.94%53.99M230.47%39.27M150.17%30.75M168.04%70.36M202.95%23.69M271.33%22.5M112.40%11.88M81.37%12.29M60.96%26.25M18.17%7.82M
Operating profit -128.77%-60.11M-187.05%-45.17M-136.73%-35.36M-168.93%-84.66M-176.89%-27.71M-253.94%-26.27M-142.86%-15.74M-97.36%-14.94M-68.11%-31.48M-41.30%-10.01M
Net non-operating interest income expense 7.43%3.77M15.56%4.15M65.44%3.85M661.10%12.76M255.19%3.32M374.09%3.51M3.59M2.33M6,307.41%1.68M935K
Non-operating interest income 7.43%3.77M15.56%4.15M65.44%3.85M661.10%12.76M255.19%3.32M374.09%3.51M--3.59M--2.33M--1.68M--935K
Other net income (expense) -10K100.00%2K0.00%1K-25.00%3K1K1K1K100.61%4K0
Other non- operating income (expenses) ---10K100.00%2K0.00%1K-25.00%3K--1K------1K--1K300.00%4K--0
Income before tax -147.55%-56.34M-237.81%-41.01M-149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M
Income tax
Net income -147.55%-56.34M-237.81%-41.01M-149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M
Net income continuous Operations -147.55%-56.34M-237.81%-41.01M-149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M
Minority interest income
Net income attributable to the parent company -147.55%-56.34M-237.81%-41.01M-149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -147.55%-56.34M-237.81%-41.01M-149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M
Basic earnings per share -98.25%-1.13-167.74%-0.83-37.25%-0.7-160.82%-1.99-171.20%-0.6355.81%-0.5775.21%-0.3165.09%-0.5179.74%-0.76383.01%-0.2323
Diluted earnings per share -98.25%-1.13-167.74%-0.83-37.25%-0.7-160.82%-1.99-171.20%-0.6355.81%-0.5775.21%-0.3165.09%-0.5179.74%-0.76383.01%-0.2323
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data